| |
| |
|
| Insider
Information: |
Heffernan Michael Thomas |
| Relationship: |
|
| City: |
Cary |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
107,930 |
|
|
Indirect Shares
|
163,043 |
|
|
| Direct
Value |
$1,883,851 |
|
|
|
Indirect Value
|
$5,427,701 |
|
|
| Total
Shares |
270,973 |
|
|
| Total
Value |
$7,311,552 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Collegium Pharmaceutical, Inc |
COLL |
Director |
2023-05-18 |
37,815 |
2016-04-05 |
163,043 |
Premium* |
|
|
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2018-12-12 |
0 |
2017-06-09 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2021-06-02 |
48,586 |
2018-12-12 |
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
Director |
2019-05-09 |
6,351 |
2019-05-09 |
0 |
Premium* |
|
|
Biohaven Ltd. |
BHVN |
|
2022-10-03 |
15,178 |
2022-10-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2018-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,486 |
7,486 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
21,186 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
34,886 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
48,586 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
|
– • – |
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,660 |
1,660 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
|
– • – |
2022-10-03 |
4/A |
D |
$7.50 |
$72,743 |
D/D |
(9,699) |
15,178 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
|
– • – |
2022-10-03 |
4 |
D |
$7.50 |
$41,303 |
D/D |
(5,507) |
19,370 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
|
– • – |
2022-10-03 |
4 |
OE |
$2.40 |
$72,729 |
D/D |
23,217 |
24,877 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman/Pres/CEOOfficer |
• • – |
2015-05-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
163,043 |
|
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman/Pres/CEOOfficer |
• • – |
2015-05-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
355,309 |
|
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2016-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
18,135 |
373,444 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2016-04-05 |
4 |
OE |
$0.48 |
$33,905 |
D/D |
13,604 |
387,048 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2016-07-29 |
4 |
A |
$10.31 |
$12,496 |
D/D |
1,212 |
551,303 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2017-01-27 |
4 |
A |
$10.08 |
$12,489 |
D/D |
1,239 |
552,542 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2017-01-31 |
4 |
OE |
$0.48 |
$1,446 |
D/D |
3,013 |
555,555 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2017-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
610,555 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2017-03-17 |
4 |
D |
$14.95 |
$22,006 |
D/D |
(1,472) |
609,083 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2017-07-28 |
4 |
A |
$10.60 |
$6,784 |
D/D |
640 |
609,723 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2017-08-04 |
4 |
D |
$12.39 |
$9,119 |
D/D |
(736) |
608,987 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2017-11-15 |
4 |
AS |
$15.53 |
$776,500 |
D/D |
(50,000) |
558,987 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2018-01-19 |
4 |
AS |
$22.50 |
$450,000 |
D/D |
(20,000) |
538,987 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2018-01-22 |
4 |
AS |
$25.00 |
$89,800 |
D/D |
(3,592) |
535,395 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2018-01-23 |
4 |
AS |
$25.01 |
$410,364 |
D/D |
(16,408) |
518,987 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2018-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
593,987 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2018-01-26 |
4 |
A |
$10.17 |
$10,617 |
D/D |
1,044 |
595,031 |
0 |
- |
|
81 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
